DK1501819T3 - Østrogenreceptormodulatorer - Google Patents
ØstrogenreceptormodulatorerInfo
- Publication number
- DK1501819T3 DK1501819T3 DK03736470.0T DK03736470T DK1501819T3 DK 1501819 T3 DK1501819 T3 DK 1501819T3 DK 03736470 T DK03736470 T DK 03736470T DK 1501819 T3 DK1501819 T3 DK 1501819T3
- Authority
- DK
- Denmark
- Prior art keywords
- estrogen
- compounds
- functioning
- disease
- gynecomastia
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/06—Six-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37523702P | 2002-04-24 | 2002-04-24 | |
PCT/US2003/012103 WO2003091239A1 (en) | 2002-04-24 | 2003-04-18 | Estrogen receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1501819T3 true DK1501819T3 (da) | 2011-01-10 |
Family
ID=29270611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03736470.0T DK1501819T3 (da) | 2002-04-24 | 2003-04-18 | Østrogenreceptormodulatorer |
Country Status (13)
Country | Link |
---|---|
US (1) | US7138426B2 (da) |
EP (1) | EP1501819B1 (da) |
JP (1) | JP4554219B2 (da) |
AT (1) | ATE481397T1 (da) |
AU (1) | AU2003237084C1 (da) |
CA (1) | CA2484038C (da) |
CY (1) | CY1111195T1 (da) |
DE (1) | DE60334202D1 (da) |
DK (1) | DK1501819T3 (da) |
ES (1) | ES2350446T3 (da) |
PT (1) | PT1501819E (da) |
SI (1) | SI1501819T1 (da) |
WO (1) | WO2003091239A1 (da) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2588180A1 (en) * | 2004-12-17 | 2006-06-22 | Bionovo, Inc. | Method of using extracts of epimedium species |
EP1944301A4 (en) | 2005-10-27 | 2012-01-04 | Msd Kk | NEW BENZOXATHIIN DERIVATIVES |
EP1991539A4 (en) * | 2006-02-28 | 2010-08-25 | Astrazeneca Ab | NEW SALTS OF INDIGENOUS DERIVATIVES AND THEIR USE IN MEDICINE |
WO2008002490A2 (en) * | 2006-06-23 | 2008-01-03 | Radius Health, Inc. | Treatment of vasomotor symptoms with selective estrogen receptor modulators |
US20080119444A1 (en) * | 2006-11-16 | 2008-05-22 | Steven Lehrer | Methods and compositions for the treatment of cancer |
EA019833B1 (ru) | 2007-01-22 | 2014-06-30 | ДЖиТиЭкс, ИНК. | Вещества, связывающие ядерные рецепторы |
US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
US9623021B2 (en) * | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
EP2826475B1 (en) | 2007-10-16 | 2019-03-20 | Repros Therapeutics Inc. | Trans-clomiphene for treating diabetes in hypogonadal men |
US7902147B2 (en) * | 2007-11-05 | 2011-03-08 | Duke University | Chronic lymphocytic leukemia prognosis and treatment |
EP2489656A1 (en) | 2007-12-21 | 2012-08-22 | Ligand Pharmaceuticals Inc. | Selective androgen receptor modulators (sarms) and uses thereof |
US20100087402A1 (en) * | 2008-09-29 | 2010-04-08 | Vivus, Inc. | Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders |
PT2568806T (pt) | 2010-05-12 | 2016-08-05 | Radius Health Inc | Regimes terapêuticos |
EP3205648A1 (en) | 2010-06-10 | 2017-08-16 | Seragon Pharmaceuticals, Inc. | Estrogen receptor modulators and uses thereof |
US8853423B2 (en) | 2010-06-17 | 2014-10-07 | Seragon Pharmaceuticals, Inc. | Indane estrogen receptor modulators and uses thereof |
EP2621901B1 (en) | 2010-09-28 | 2015-07-29 | Radius Health, Inc | Selective androgen receptor modulators |
EP2655367B1 (en) | 2010-12-24 | 2016-07-06 | Merck Sharp & Dohme B.V. | N-substituted azetidine derivatives |
EP2791133B1 (en) | 2011-12-14 | 2019-04-17 | Seragon Pharmaceuticals, Inc. | Fluorinated estrogen receptor modulators and uses thereof |
EA201490897A1 (ru) | 2011-12-16 | 2015-03-31 | Олема Фармасьютикалс, Инк. | Новые бензопирановые соединения, композиции и их применение |
WO2013130832A1 (en) | 2012-02-29 | 2013-09-06 | Repros Therapeutics Inc. | Combination therapy for treating androgen deficiency |
CA2898482A1 (en) | 2013-02-22 | 2014-08-28 | Linda L. Brockunier | Antidiabetic bicyclic compounds |
US10420734B2 (en) | 2014-03-28 | 2019-09-24 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
US9421264B2 (en) | 2014-03-28 | 2016-08-23 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
EP3373967B9 (en) | 2015-11-10 | 2023-10-04 | Paracrine Therapeutics AB | Treatment of er-negative breast cancer with an pdgf-cc inhibitor and an anti estrogen |
TN2018000285A1 (en) | 2016-02-15 | 2020-01-16 | Sanofi Sa | 6,7-dihydro-5h-benzo[7]annulene derivatives as estrogen receptor modulators |
PL3474841T3 (pl) | 2016-06-22 | 2022-07-11 | Ellipses Pharma Ltd | Sposoby leczenia nowotworu złośliwego piersi ar+ |
JP6946430B2 (ja) * | 2016-11-17 | 2021-10-06 | サノフイSanofi | 新規の置換n−(3−フルオロプロピル)−ピロリジン化合物、それを製造するための方法、およびその治療的使用 |
JP2020514291A (ja) | 2017-01-05 | 2020-05-21 | ラジウス ファーマシューティカルズ,インコーポレイテッド | Rad1901−2hclの多形性形態 |
WO2018138739A1 (en) | 2017-01-27 | 2018-08-02 | Sun Pharma Advanced Research Company Limited | Novel antiestrogenic heterocyclic compounds |
EP3434272A1 (en) | 2017-07-25 | 2019-01-30 | Sanofi | Combination comprising palbociclib and 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic acid |
AU2019210129B2 (en) * | 2018-01-22 | 2023-09-28 | Radius Pharmaceuticals, Inc. | Estrogen receptor-modulating compounds |
US11643385B2 (en) | 2018-07-04 | 2023-05-09 | Radius Pharmaceuticals, Inc. | Polymorphic forms of RAD1901-2HCl |
BR112021003440A2 (pt) | 2018-09-07 | 2021-05-18 | Sanofi | sais de 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil) pirrolidin-3-il]oxifenil]-8,9-di-hidro-7h-benzo[7]anuleno-2-carboxilato de metila e seu processo de preparação |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990087187A (ko) | 1996-02-24 | 1999-12-15 | 스타르크, 카르크 | 2-헤타로일시클로헥산-1,3-디온 |
US5985306A (en) * | 1996-10-28 | 1999-11-16 | Novo Nordisk A/S | (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes |
FR2762598A1 (fr) | 1997-04-25 | 1998-10-30 | Adir | Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennnent |
US6465445B1 (en) * | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
EP1333827A2 (en) | 2000-10-19 | 2003-08-13 | Merck & Co., Inc. | Estrogen receptor modulators |
EP1328522A2 (en) | 2000-10-19 | 2003-07-23 | Merck & Co., Inc. | Estrogen receptor modulators |
US6750213B2 (en) * | 2000-10-19 | 2004-06-15 | Merck & Co., Inc. | Estrogen receptor modulators |
US20030225132A1 (en) * | 2002-04-11 | 2003-12-04 | Dininno Frank P. | Estrogen receptor modulators |
-
2003
- 2003-04-18 SI SI200331909T patent/SI1501819T1/sl unknown
- 2003-04-18 AT AT03736470T patent/ATE481397T1/de active
- 2003-04-18 PT PT03736470T patent/PT1501819E/pt unknown
- 2003-04-18 US US10/512,172 patent/US7138426B2/en not_active Expired - Lifetime
- 2003-04-18 DK DK03736470.0T patent/DK1501819T3/da active
- 2003-04-18 WO PCT/US2003/012103 patent/WO2003091239A1/en active Application Filing
- 2003-04-18 AU AU2003237084A patent/AU2003237084C1/en not_active Ceased
- 2003-04-18 EP EP03736470A patent/EP1501819B1/en not_active Expired - Lifetime
- 2003-04-18 CA CA2484038A patent/CA2484038C/en not_active Expired - Fee Related
- 2003-04-18 DE DE60334202T patent/DE60334202D1/de not_active Expired - Lifetime
- 2003-04-18 ES ES03736470T patent/ES2350446T3/es not_active Expired - Lifetime
- 2003-04-18 JP JP2003587798A patent/JP4554219B2/ja not_active Expired - Fee Related
-
2010
- 2010-12-13 CY CY20101101150T patent/CY1111195T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP1501819B1 (en) | 2010-09-15 |
JP2005529136A (ja) | 2005-09-29 |
ATE481397T1 (de) | 2010-10-15 |
US7138426B2 (en) | 2006-11-21 |
WO2003091239A1 (en) | 2003-11-06 |
AU2003237084C1 (en) | 2009-03-26 |
DE60334202D1 (de) | 2010-10-28 |
US20050234245A1 (en) | 2005-10-20 |
EP1501819A1 (en) | 2005-02-02 |
JP4554219B2 (ja) | 2010-09-29 |
CA2484038A1 (en) | 2003-11-06 |
CY1111195T1 (el) | 2015-06-11 |
ES2350446T3 (es) | 2011-01-24 |
PT1501819E (pt) | 2010-11-11 |
AU2003237084B2 (en) | 2008-11-20 |
AU2003237084A1 (en) | 2003-11-10 |
CA2484038C (en) | 2011-10-18 |
EP1501819A4 (en) | 2006-06-21 |
SI1501819T1 (sl) | 2011-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1501819T3 (da) | Østrogenreceptormodulatorer | |
ATE524170T1 (de) | Östrogenrezeptor modulatoren | |
TW200631933A (en) | Estrogen receptor modulators | |
WO2002091993A3 (en) | Estrogen receptor modulators | |
MX2007006878A (es) | Moduladores del receptor de estrogeno. | |
ATE329904T1 (de) | Östrogenrezeptormodulatoren | |
WO2002032377A3 (en) | Estrogen receptor modulators | |
WO2004073612A3 (en) | Estrogen receptor modulators | |
WO2004091488A3 (en) | Estrogen receptor modulators | |
WO2006081152A3 (en) | Estrogen receptor modulators | |
MX2009000714A (es) | Moduladores de receptor de androgeno selectivos, analogos y derivados de los mismos. | |
ATE517871T1 (de) | Östrogenrezeptormodulatoren | |
WO2002032373A3 (en) | Estrogen receptor modulators | |
AU2003288644A1 (en) | Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof | |
WO2005097141A3 (en) | Estrogen receptor modulators | |
AR039282A1 (es) | Moduladores de receptores de estrogeno | |
WO2004073610A3 (en) | Estrogen receptor modulators | |
ATE301629T1 (de) | Estrogenrezeptorliganden und verfahren | |
WO2002058639A3 (en) | Pyranoflavonoid compounds and their use as estrogen receptor modulators | |
WO2004026887A3 (en) | Estrogen receptor modulators | |
WO2008057309A3 (en) | Estrogen receptor modulators | |
EA201100226A1 (ru) | Производные эстратриена, содержащие гетероциклические биоизостеры для фенольного а-кольца | |
DOP2002000384A (es) | Moduladores de receptores estrogenicos. | |
DOP2005000224A (es) | Moduladores de los receptores de estrogeno |